» Articles » PMID: 9811301

Tumor-associated Macrophages As Targets for Cancer Therapy

Overview
Specialty Oncology
Date 1998 Nov 12
PMID 9811301
Citations 32
Authors
Affiliations
Soon will be listed here.
Citing Articles

Inflammation in cancer: therapeutic opportunities from new insights.

Xie Y, Liu F, Wu Y, Zhu Y, Jiang Y, Wu Q Mol Cancer. 2025; 24(1):51.

PMID: 39994787 PMC: 11849313. DOI: 10.1186/s12943-025-02243-8.


Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages.

Wu S, Lv X, Wei H, Chen W, Zheng J, Li X J Cell Mol Med. 2023; 27(24):4133-4144.

PMID: 37864310 PMC: 10746935. DOI: 10.1111/jcmm.17998.


Topical N-phosphonacetyl-l-aspartate is a dual action candidate for treating non-melanoma skin cancer.

Mahen K, Markley L, Bogart J, Klatka H, Krishna V, Maytin E Exp Dermatol. 2023; 32(9):1485-1497.

PMID: 37309615 PMC: 10527533. DOI: 10.1111/exd.14853.


Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer.

Ephraim R, Feehan J, Fraser S, Nurgali K, Apostolopoulos V Cancers (Basel). 2022; 14(24).

PMID: 36551617 PMC: 9776998. DOI: 10.3390/cancers14246131.


Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics.

Zhu L, Zhong Y, Wu S, Yan M, Cao Y, Mou N Mater Today Bio. 2022; 14:100228.

PMID: 35265826 PMC: 8898969. DOI: 10.1016/j.mtbio.2022.100228.